Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 5/20 | 0.37 |
| ▸ | PPARD | Q03181 | 5/20 | 0.37 |
| ▸ | PPARA | Q07869 | 5/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230057 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL1870547 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL905402 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL379359 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL905699 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL905720 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL34381 | 0.96 | TSHR (0.48) | LMNATSHRNFKB1PMP22SLC22A6 | |
| Ethylene Glycol SCHEMBL6523934 | 0.90 | TSHR (0.44) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL43574 | 0.89 | EGLN1 (0.43) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL2593466 | 0.87 | TSHR (0.41) | LMNATSHRNFKB1PMP22SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683964-A2 | POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4665307-A1 | BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4630058-A2 | CHEMICAL TISSUE ABLATION WITH HYDROGEL MATRIX AND CORRESPONDING MEDICAL APPLICATIONS | Pramand LLC (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4568658-A1 | ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| US-20250144012-A1 | INTRACAMERAL DRUG DELIVERY DEPOTS | INCEPT, LLC | 2025-05-08 | — | — | US | claimed |
| CN-119947711-A | Organogels for sustained drug delivery, methods of preparation and uses thereof | 视尔普斯眼科公司 | 2025-05-06 | — | — | CN | claimed |
| US-12251466-B2 | Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels | Pramand LLC (US) | 2025-03-18 | — | — | US | claimed |
| EP-4518920-A1 | WATER ACTIVATED HYDROGEL-BASED MEDICAL PATCHES, FLEXIBLE SUBSTRATES AND METHODS OF MAKING AND USING SUCH PATCHES | Pramand LLC (US) | 2025-03-12 | — | — | EP | claimed |
| EP-4511074-A1 | SINGLE SOLUTION HYDROGELS WITH COVALENT BONDING FORMED IN SITU, COMPOSITION DESIGN AND MEDICAL PROCEDURES USING THE HYDROGELS | Pramand LLC (US) | 2025-02-26 | — | — | EP | claimed |
| WO-2023205051-A9 | SINGLE SOLUTION HYDROGELS WITH COVALENT BONDING FORMED IN SITU, COMPOSITION DESIGN AND MEDICAL PROCEDURES USING THE HYDROGELS | Pramand LLC (US) | 2024-11-14 | — | — | WO | claimed |
| EP-4197527-A1 | INTRACAMERAL DRUG DELIVERY DEPOTS | Incept, LLC (US) | 2023-06-21 | — | — | EP | claimed |
| US-20230183475-A1 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | SPIRAL THERAPEUTICS INC. | 2023-06-15 | — | — | US | claimed |
| WO-2021231563-A9 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | SPIRAL THERAPEUTICS INC. (US) | 2023-05-11 | — | — | WO | claimed |
| EP-4149431-A1 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | Spiral Therapeutics Inc. (US) | 2023-03-22 | — | — | EP | claimed |
| CN-115666511-A | Gelling solution for applying compounds to the inner ear | 斯皮拉尔诊疗有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-20220401356-A1 | INTRACAMERAL DRUG DELIVERY DEPOTS | INCEPT, LLC | 2022-12-22 | — | — | US | claimed |
| EP-4090261-A1 | METHODS AND DEVICES FOR IN SITU FORMED NERVE CAP WITH RAPID RELEASE | Tulavi Therapeutics, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| CN-113827766-B | Drug-loaded surgical sealant and preparation method and application thereof | 赛克赛斯生物科技股份有限公司 | 2022-05-24 | — | — | CN | claimed |
| WO-2021231563-A1 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | SPIRAL THERAPEUTICS INC. (US) | 2021-11-18 | — | — | WO | claimed |
| US-10272164-B2 | Implants and biodegradable tissue markers | INCEPT, LLC (US) | 2019-04-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144012-A1 | INTRACAMERAL DRUG DELIVERY DEPOTS | MMP1, UACA, IDE | LMNA 2426/4885TSHR 994/4885NFKB1 816/4885 |
| US-20220401356-A1 | INTRACAMERAL DRUG DELIVERY DEPOTS | MMP1, UACA, IDE | LMNA 2426/4885TSHR 994/4885NFKB1 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.